Life Sciences & Healthcare Innovation Program
Biotech + Breaking Glass: Leading Women in Life Sciences
Event summary
11:00 am – 12:00 pm PT
2:00 – 3:00 pm ET
7:00 – 8:00 pm GMT
Join us for our next Biotech + Breaking Glass: Leading Women in Life Sciences event. This series features women in the life sciences industry sharing and celebrating their stories, obstacles and milestones.
Our latest installment will feature Clare Ozawa, Managing Director at Versant Ventures, a leading healthcare venture capital firm with $4.2 billion under management that is committed to helping exceptional entrepreneurs build the next generation of great companies. Clare will be joined by Cooley lawyers Madison Jones and Courtney Thorne and will discuss topics around her role at Versant and exceptional career to date.
Clare Ozawa, Ph.D., became a Versant Managing Director in 2017 and leads investments in San Diego and the Bay Area. Clare previously oversaw strategic business operations for all Inception Sciences research sites across North America. During her tenure at Inception, she assumed leadership roles in the creation and management of six new companies launched in partnership with academic researchers and major biopharmaceutical companies. Clare joined Versant from Novartis Pharma, where she worked in the Office of the CEO, leading strategic initiatives for the Novartis Pharma Executive Committee. Previously, Clare was at McKinsey & Company where she advised clients across the biopharmaceutical sector.
• Madison Jones – Partner, Cooley
• Courtney Thorne – Partner, Cooley
• Clare Ozawa – Managing Director, Versant Ventures
This virtual event is part of our 2022 Life Sciences & Healthcare Innovation Program, Cooley’s 15th annual event in conjunction with the J.P. Morgan Healthcare Conference.
Event details and registration
For more information, please email Savannah Euler.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.